Analyst upgrades: NOC, PFWD and CLS

More

MOST NOTEWORTHY: Northrop Grumman, Phase Forward and Celestica were today's noteworthy upgrades:
  • Cowen upgraded Northrop Grumman (NYSE: NOC) to Outperform from Neutral following the Q1 report based on accelerating growth. Shares were also upgraded at JP Morgan to Overweight from Neutral.
  • Friedman Billings upgraded Phase Forward (NASDAQ: PFWD) to Outperform from Market Perform following the solid Q1 report and views guidance as beatable.
  • CIBC raised Celestica (NYSE: CLS) to Sector Outperformer from Sector Performer following Q1 results, citing end markets that look stable.
OTHER UPGRADES:
  • JP Morgan upgraded the Consumer Discretionary Sector to Overweight from Underweight.
  • Wendy's (NYSE: WEN) was raised to Neutral from Sell at Goldman.
  • Progenics Pharmaceuticals (NASDAQ: PGNX) was upgraded at Citigroup to Hold from Sell.
  • Merrill Lynch raised Wal-Mart (NYSE: WMT) to Buy from Neutral.
Symbol Lookup
IndexesChangePrice
DJIA-32.2710,026.37
NASDAQ-2.762,148.11
S&P 500-2.971,067.55

Last updated: February 10, 2010: 09:49 AM

Hot Stocks

DailyFinance Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

WalletPop Headlines